Tirzepatide – 5mg is a dual GIP and GLP-1 receptor agonist peptide designed for research. Investigate its role in glucose metabolism, insulin sensitivity, and fat loss potential.
Bacteriostatic Water – 10ml is a sterile, multi-use diluent designed for research purposes, commonly used to reconstitute peptides and compounds in laboratory settings.
Retatrutide – 5mg is a synthetic peptide studied for its potential effects on glucose metabolism, weight management, cardiovascular health, and inflammation.
Semaglutide – 5mg is a GLP-1 receptor agonist studied for glycemic control, weight loss, cardiovascular protection, and potential benefits in NAFLD and neuroprotection.
body {
font-family: ‘Lato’, sans-serif;
color: #333;
line-height: 1.8;
margin: 0;
padding: 0;
}
h1 {
font-family: ‘Montserrat’, sans-serif;
font-size: 36px;
font-weight: bold;
text-align: center;
color: #1e93a7;
}
h2 {
font-family: ‘Montserrat’, sans-serif;
font-size: 24px;
font-weight: 600;
color: #1e93a7;
}
h3 {
font-family: ‘Montserrat’, sans-serif;
font-size: 18px;
font-weight: 600;
color: #1e93a7;
}
.highlight {
background-color: #e6f7f8;
border: 1px solid #BCE0E3;
padding: 20px;
border-radius: 8px;
margin-bottom: 20px;
}
.disclaimer {
font-size: 12px;
color: #555;
text-align: center;
background-color: #f7f9fa;
border: 1px solid #E0E6EA;
padding: 15px;
border-radius: 8px;
}
.references {
font-family: ‘Lato’, sans-serif;
font-size: 14px;
color: #1e93a7;
line-height: 1.8;
}
Tirzepatide – 5mg
Tirzepatide – 5mg is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This advanced peptide is designed for laboratory research to explore its effects on glycemic control, weight loss, cardiovascular health, and lipid metabolism. It is not for human or clinical use.
Chemical Information
- Chemical Formula: C₈₂H₁₁₁N₁₉O₂₀
- Molecular Mass: 1891.12 g/mol
- Synonyms: LY3298176, Dual GIP/GLP-1 Receptor Agonist, Ozempic, Rybelsus
- CAS Number: 2023788-19-2
- PubChem ID: 129070241
- Total Amount: 5 mg
- Shelf Life: 2 years when stored at -20°C
What is Tirzepatide?
Tirzepatide is a synthetic peptide that mimics the actions of two incretin hormones: GIP and GLP-1. These hormones are vital for regulating glucose metabolism and promoting weight loss. Tirzepatide’s dual mechanism has made it a key research candidate in Type 2 Diabetes and obesity management studies.
Research Benefits of Tirzepatide – 5mg
1. Enhanced Glycemic Control
By targeting both GIP and GLP-1 receptors, Tirzepatide enhances insulin secretion and inhibits glucagon release in a glucose-dependent manner. This mechanism helps lower postprandial blood sugar levels effectively and reduces the risk of hypoglycemia [1].
2. Weight Loss
Tirzepatide has demonstrated significant potential for weight loss by reducing appetite and delaying gastric emptying. Research shows its efficacy surpasses that of traditional GLP-1 agonists, making it a valuable subject for studies on obesity and metabolic syndrome [2].
3. Cardiovascular Protection
Studies indicate that Tirzepatide may improve lipid profiles and reduce cardiovascular risk factors, including cholesterol levels and body weight. These effects highlight its potential for addressing the elevated cardiovascular risks associated with Type 2 Diabetes [3].
4. Improved Lipid Metabolism
Tirzepatide has been shown to reduce triglycerides, LDL cholesterol, and total cholesterol while increasing HDL cholesterol. These findings make it a promising research compound for improving overall metabolic health [4].
5. Potential in Non-Alcoholic Fatty Liver Disease (NAFLD)
Its weight loss and metabolic benefits have spurred interest in Tirzepatide’s potential effects on non-alcoholic fatty liver disease (NAFLD). Studies suggest it may reduce liver fat and improve liver function [5].
Warning: This product is for laboratory research purposes only. Not for human or animal use. Proper handling and storage by qualified personnel in a controlled environment are required. Misuse may result in health risks.
Scientific References
- Frias, J.P., et al. “Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes.” The New England Journal of Medicine, vol. 385, no. 6, 2021, pp. 503-515.
- Jastreboff, A.M., et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” The New England Journal of Medicine, vol. 387, no. 3, 2022, pp. 205-216.
- Sattar, N., et al. “Tirzepatide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.” Diabetes Care, vol. 45, no. 2, 2022, pp. 517-525.
- Wadden, T.A., et al. “Effects of Tirzepatide on Body Weight and Cardiometabolic Risk Factors.” Diabetes, Obesity and Metabolism, vol. 23, no. 10, 2021, pp. 2223-2232.
- Kuchay, M.S., et al. “Effects of Tirzepatide on Liver Fat Content in Patients with Type 2 Diabetes.” Diabetes Care, vol. 45, no. 1, 2022, pp. 105-111.
i>
Based on 0 reviews
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
|
|
0% |
Related Products
Retatrutide – 5mg is a synthetic peptide studied for its potential effects on glucose metabolism, weight management, cardiovascular health, and inflammation.
Epitalon – 10mg is a synthetic peptide studied for anti-aging, telomere activation, immune support, and neuroprotection. For research use only.
BPC 157 – 5mg is a research peptide studied for its potential in tissue healing, inflammation reduction, and organ protection in experimental models.
Ipamorelin – 5mg is a research peptide studied for its role in stimulating growth hormone release, promoting muscle growth, enhancing recovery, and supporting anti-aging research.
TB500 (Thymosin Beta-4) – 5mg is a research peptide studied for its potential in tissue repair, wound healing, inflammation reduction, and angiogenesis.

















Reviews
There are no reviews yet.